Friday, August 14, 2020

ViaCyte Names VP

San Diego-based ViaCyte, a developer of regenerative medicine products based on stem cells, said this week that it has named Manasi Sinha Jaiman, M.D., M.P.H. as Vice President, Clinical Development. Dr. Jaiman was most recently at Covance Clinical Development Services, where she was Senior Medical Director. She also was an an attending physician at Harvard Medical School and Massachusetts General Hospital. ViaCyte is developing stem-cell derived products aimed at providing a cure for people with type 1 diabetes, and as a treatment for those with insulin-requiring type 2 diabetes.